News/Case Summaries

Merck board approves $5 billion in stock buybacks

April 27, 2011

Merck & Co. Inc. says its board of directors approved the buyback of up to $5 billion in common stock for the drug developer's treasury.

The company, based in Whitehouse Station, N.J., says the purchases have no time limit. Overall, the company is now authorized to buy back up to $6.4 billion in common stock.

Merck has about 3.08 billion shares of common stock outstanding.

Shares closed at $35.06 Tuesday.

Copyright 2011 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.